FoliuMed claims it has shipped the largest ever delivery of medical cannabis from Colombia to Australia. According to FoliuMed, Australia is the second-largest medical cannabis market outside North America, after Germany, with over 100,000 patients.
"This is the first of two shipments which allow our customer to supply about 5% of Australian demand at less than half the cost compared to local production," stated FoliuMed Founder and CEO, Oliver Zugel.
With Australian wages and energy prices among the highest in the world, producing affordable medical cannabis locally has proven to be a challenge. This has become a big issue for patients who pay over 200 Australian dollars ($150) for a monthly dose, available only under prescription. Unlike in Germany where cannabis is covered by health insurance, Australian patients pay for their medicine out of pocket.
"This limits access to medical cannabis to the well-heeled or those willing to take the risk to buy more cheaply from the black market," Zugel added.
Foliumed's shipment consists of pharmaceutical cannabis ingredients produced at its Colombian cultivation site at the foothills of the Andes.
"With ideal climatic conditions, our energy consumption is minimal and we grow the plants organically," stated FoliuMed co-founder and LATAM CEO Diego Felipe Navarro. "Our teams in Colombia and Germany have worked for over a year with our customer, the health authorities and the Colombian government to ensure we adhere to the strict quality standards imposed by the Australian drug regulator TGA."
The TGA recently increased the quality demands on medical cannabis imports making them comparable to how pharmaceutical products must be manufactured locally and in Europe.
"Given our German operations are EU-GMP certified, we offer Australian importers a full range of affordable solutions compliant with the new regulations," Zugel said.
Related News
Clever Leaves Teams Up With FoliuMed To Import Colombian Cannabis EU-GMP Bulk Extracts Into Germany
FoliuMed seals white label cannabis deals in South America
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.